Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Prominent 'Y' descent is an ominous sign of a poorer prognosis in heart failure with preserved ejection fraction.

Harada D, Asanoi H, Noto T, Takagawa J.

ESC Heart Fail. 2019 Aug;6(4):799-808. doi: 10.1002/ehf2.12460. Epub 2019 May 20.

2.

Multicenter, Prospective Study on Respiratory Stability During Recovery From Deterioration of Chronic Heart Failure.

Takagawa J, Asanoi H, Tobushi T, Kumagai N, Kadokami T, Dohi K, Joho S, Wada O, Koyama T, Haruki N, Ando SI, Momomura SI; PROST Investigators.

Circ J. 2018 Dec 25;83(1):164-173. doi: 10.1253/circj.CJ-18-0519. Epub 2018 Nov 13.

3.

Impact of right ventricular distensibility on congestive heart failure with preserved left ventricular ejection fraction in the elderly.

Harada D, Aasanoi H, Ushijima R, Noto T, Takagawa J, Ishise H, Inoue H.

Heart Vessels. 2018 Jun;33(6):605-614. doi: 10.1007/s00380-017-1092-2. Epub 2017 Dec 13.

PMID:
29234860
4.

Independent prognostic importance of respiratory instability and sympathetic nerve activity in patients with chronic heart failure.

Asanoi H, Harada D, Oda Y, Ueno H, Takagawa J, Ishise H, Goso Y, Joho S, Inoue H.

J Cardiol. 2017 Nov;70(5):476-483. doi: 10.1016/j.jjcc.2017.02.011. Epub 2017 Apr 22.

5.

Slow and deep respiration suppresses steady-state sympathetic nerve activity in patients with chronic heart failure: from modeling to clinical application.

Harada D, Asanoi H, Takagawa J, Ishise H, Ueno H, Oda Y, Goso Y, Joho S, Inoue H.

Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1159-68. doi: 10.1152/ajpheart.00109.2014. Epub 2014 Aug 15.

6.

Advanced Donor Age Impairs Bone Marrow Cell Therapeutic Efficacy for Cardiac Disease.

Wang X, Takagawa J, Haddad DJ, Pinnamaneni K, Zhang Y, Sievers RE, Grossman W, Yeghiazarians Y, Springer ML.

J Tissue Sci Eng. 2011 Nov 18;S3. pii: 002.

7.

Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response.

Wang X, Takagawa J, Lam VC, Haddad DJ, Tobler DL, Mok PY, Zhang Y, Clifford BT, Pinnamaneni K, Saini SA, Su R, Bartel MJ, Sievers RE, Carbone L, Kogan S, Yeghiazarians Y, Hermiston M, Springer ML.

Sci Transl Med. 2011 Sep 14;3(100):100ra90. doi: 10.1126/scitranslmed.3002814.

8.

Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarction.

Zhang Y, Sievers RE, Prasad M, Mirsky R, Shih H, Wong ML, Angeli FS, Ye J, Takagawa J, Koskenvuo JW, Springer ML, Grossman W, Boyle AJ, Yeghiazarians Y.

Cardiovasc Pathol. 2011 Jul-Aug;20(4):204-12. doi: 10.1016/j.carpath.2010.06.007. Epub 2010 Jul 29.

PMID:
20667749
9.

Combining angiogenic gene and stem cell therapies for myocardial infarction.

Pons J, Huang Y, Takagawa J, Arakawa-Hoyt J, Ye J, Grossman W, Kan YW, Su H.

J Gene Med. 2009 Sep;11(9):743-53. doi: 10.1002/jgm.1362.

PMID:
19554624
10.

Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy.

Yeghiazarians Y, Zhang Y, Prasad M, Shih H, Saini SA, Takagawa J, Sievers RE, Wong ML, Kapasi NK, Mirsky R, Koskenvuo J, Minasi P, Ye J, Viswanathan MN, Angeli FS, Boyle AJ, Springer ML, Grossman W.

Mol Ther. 2009 Jul;17(7):1250-6. doi: 10.1038/mt.2009.85. Epub 2009 Apr 21.

11.

VEGF improves survival of mesenchymal stem cells in infarcted hearts.

Pons J, Huang Y, Arakawa-Hoyt J, Washko D, Takagawa J, Ye J, Grossman W, Su H.

Biochem Biophys Res Commun. 2008 Nov 14;376(2):419-22. doi: 10.1016/j.bbrc.2008.09.003. Epub 2008 Sep 18.

PMID:
18789891
12.

Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heart.

Su H, Takagawa J, Huang Y, Arakawa-Hoyt J, Pons J, Grossman W, Kan YW.

Int J Cardiol. 2009 Apr 3;133(2):191-7. doi: 10.1016/j.ijcard.2007.12.034. Epub 2008 Mar 4.

13.

Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches.

Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, Wang Y, Yeghiazarians Y, Lee RJ, Grossman W, Springer ML.

J Appl Physiol (1985). 2007 Jun;102(6):2104-11. Epub 2007 Mar 8.

14.

Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarction.

Zhang Y, Takagawa J, Sievers RE, Khan MF, Viswanathan MN, Springer ML, Foster E, Yeghiazarians Y.

Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1187-92. Epub 2006 Oct 6.

15.

AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.

Su H, Huang Y, Takagawa J, Barcena A, Arakawa-Hoyt J, Ye J, Grossman W, Kan YW.

Gene Ther. 2006 Nov;13(21):1495-502. Epub 2006 Jun 15.

16.

Central sympathetic inhibition augments sleep-related ultradian rhythm of parasympathetic tone in patients with chronic heart failure.

Yamazaki T, Asanoi H, Ueno H, Yamada K, Takagawa J, Kameyama T, Hirai T, Ishizaka S, Nozawa T, Inoue H.

Circ J. 2005 Sep;69(9):1052-6.

17.

Circadian dynamics of heart rate and physical activity in patients with heart failure.

Yamazaki T, Asanoi H, Ueno H, Yamada K, Takagawa J, Kameyama T, Hirai T, Nozawa T, Inoue H.

Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):241-9.

PMID:
15835387
18.

Role of central sympathoexcitation in enhanced hypercapnic chemosensitivity in patients with heart failure.

Yamada K, Asanoi H, Ueno H, Joho S, Takagawa J, Kameyama T, Hirai T, Nozawa T, Inoue H.

Am Heart J. 2004 Dec;148(6):964-70.

PMID:
15632879
19.

Attenuated respiratory modulation of chemoreflex-mediated sympathoexcitation in patients with chronic heart failure.

Ueno H, Asanoi H, Yamada K, Oda Y, Takagawa J, Kameyama T, Hirai T, Nozawa T, Takashima S, Inoue H.

J Card Fail. 2004 Jun;10(3):236-43.

PMID:
15190534
20.

Parametric system identification of arterial baroreflex with random perturbation of blood pressure in normal subjects.

Yamada K, Asanoi H, Takagawa J, Joho S, Kameyama T, Hirai T, Nozawa T, Inoue H.

J Cardiovasc Pharmacol. 2003 Dec;42 Suppl 1:S11-3.

PMID:
14871021
21.

Cardiac sympathetic denervation modulates the sympathoexcitatory response to acute myocardial ischemia.

Joho S, Asanoi H, Takagawa J, Kameyama T, Hirai T, Nozawa T, Umeno K, Shimizu M, Seto H, Inoue H.

J Am Coll Cardiol. 2002 Feb 6;39(3):436-42.

22.

[A case of craniopharyngioma with chemical meningitis as an initial symptom].

Nishio Y, Takashima S, Taguchi Y, Takagawa J, Inoue H, Hirashima Y, Endo S.

No To Shinkei. 2001 Oct;53(10):957-60. Japanese.

PMID:
11725506
23.

[Chronic necrotizing pulmonary aspergillosis resistant to antimycotic drugs and treated by partial pulmonary resection].

Takagawa J, Maruyama M, Yoshida Y, Arai N, Matsui S, Yamashita N, Sugiyama S, Kobayashi M.

Nihon Kokyuki Gakkai Zasshi. 1998 Jun;36(6):519-23. Japanese.

PMID:
9754002

Supplemental Content

Loading ...
Support Center